Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Acquisitions & Divestments (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Change in Acquisitions & Divestments for 15 consecutive years, with $290.3 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Acquisitions & Divestments rose 0.7% year-over-year to $290.3 million; the TTM value through Mar 2026 reached $1.0 billion, up 40.3%, while the annual FY2025 figure was $1.0 billion, 26.26% up from the prior year.
  • Change in Acquisitions & Divestments hit $290.3 million in Q1 2026 for Agios Pharmaceuticals, up from $252.3 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $368.7 million in Q1 2024 and bottomed at $141.9 million in Q2 2024.
  • Average Change in Acquisitions & Divestments over 5 years is $233.1 million, with a median of $220.6 million recorded in 2025.
  • Year-over-year, Change in Acquisitions & Divestments surged 147.84% in 2022 and then crashed 55.06% in 2023.
  • Agios Pharmaceuticals' Change in Acquisitions & Divestments stood at $198.9 million in 2022, then fell by 6.38% to $186.2 million in 2023, then decreased by 19.36% to $150.1 million in 2024, then surged by 68.03% to $252.3 million in 2025, then grew by 15.06% to $290.3 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $290.3 million, $252.3 million, and $272.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.